He was useless? He kept a startup biotech with no product and only tantalizing hints at marketable efficacy solvent for 12 years. Right up to the midpoint of a SPA PIII pivotal trial with over a year's money in the bank and less than 100 million shares outstanding. Those of us who have more than a couple years experience investing in biotech know how rare that is. Apparently you don't.
It's heartwarming to read that someone so well informed assures us this will all turn out successfully.